Exendin-4 prevented pancreatic beta cells from apoptosis in (Type I) diabetic mouse via keap1-Nrf2 signaling

Area of Science:

• Cellular biology
• Molecular mechanisms of disease
• Endocrinology

Background:

• Nuclear factor erythroid 2-related factor 2 (Nrf2) is crucial for cellular defense against oxidative stress and environmental toxins.
• Nrf2 regulates the expression of antioxidant and detoxification enzymes, protecting cells from damage.
• Pancreatic beta-cell dysfunction and death are central to type I diabetes mellitus.

Purpose of the Study:

• To investigate the effect of exendin-4 on the Nrf2 pathway in pancreatic beta-cells.
• To determine exendin-4's role in regulating cell death and oxidative stress in the context of diabetes.
• To evaluate exendin-4 as a potential therapeutic agent for type I diabetes.

Main Methods:

• Treatment of pancreatic beta-cells and non-obese diabetic mice with exendin-4.
• Analysis of the Keap1-Nrf2-ARE pathway activation.
• Assessment of reactive oxygen species (ROS) levels and cell death (apoptosis).
• Nrf2 knockdown using siRNA to study its specific role.

Main Results:

• Exendin-4 treatment activated the Keap1-Nrf2-ARE pathway.
• Exendin-4 reduced ROS production and cell death in pancreatic beta-cells.
• Nrf2 knockdown suppressed ROS generation and increased apoptosis, counteracting exendin-4's protective effects.
• Exendin-4's protection of beta-cell viability was attenuated by Nrf2 down-regulation, affecting Bax and Bcl-2 protein levels.

Conclusions:

• Exendin-4 activates the Nrf2 pathway, offering protection to pancreatic beta-cells against oxidative stress and apoptosis.
• These findings highlight exendin-4's potential as a therapeutic strategy for type I diabetes mellitus.
• Modulation of the Nrf2 pathway by exendin-4 is critical for preserving pancreatic beta-cell function and survival.